News Channels

12 Jun 2019 Pfizer Announces Results from XELJANZ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor
12 Jun 2019 OrthoTrophix Presents Clinical Data at European Congress of Rheumatology
12 Jun 2019 BioInvent publishes first clinical data from BI-1206 Phase l/lla trials
12 Jun 2019 Sobi acquires emapalumab and related assets
12 Jun 2019 CymaBay Therapeutics Reports Topline 12-Week Data from an Ongoing Phase 2b Study of Seladelpar in Patients with Nonalcoholic Steatohepatitis
12 Jun 2019 Immunicum AB (publ) Announces Positive Topline Results from the Phase I/II Clinical Trial in GIST
12 Jun 2019 MappBio Announces Contract with BARDA for MBP091 as a pan-Marburg Medical Countermeasure
12 Jun 2019 New Subcutaneous Formulation of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) Shows Positive Results for the Treatment of Rheumatoid Arthritis (RA) In Data Presented at the Annual European Congress of Rheumatology (EULAR 2019)
12 Jun 2019 Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial
12 Jun 2019 FDA Grants Priority Review to Genentech’s Rituxan (Rituximab) in Children with Two Rare Blood Vessel Disorders
11 Jun 2019 New Two-Year Data at the 24th World Congress of Dermatology Shows SKYRIZI™ (risankizumab) Maintains Complete Skin Clearance New Two-Year Data at the 24th World Congress of Dermatology Shows SKYRIZI™ (risankizumab) Maintains Complete Skin Clearance
11 Jun 2019 Ziopharm Oncology Announces FDA Clearance of IND for Sleeping Beauty TCR-T Cell Therapy Trial at NCI
11 Jun 2019 FDA Approves Two New Indications for Merck’s KEYTRUDA® (pembrolizumab)
11 Jun 2019 Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
11 Jun 2019 Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
11 Jun 2019 BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan
11 Jun 2019 Genentech’s Gazyva (Obinutuzumab) Delivers Positive Topline Results for Phase II Lupus Nephritis Study
10 Jun 2019 FDA Grants Genentech’s Polivy Accelerated Approval for People With Previously Treated Aggressive Lymphoma
10 Jun 2019 Aptinyx Reports Positive Top-line Data from Phase 2 Study of NYX-2925 in Patients with Fibromyalgia, Demonstrating Significant Effects on Both Biomarkers and Patient-Reported Pain
10 Jun 2019 Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU and Expects Initial Clinical Results by Year End 2019

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up